Mainboard · BSE and NSEListed

GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 10:51 am IST · Source: Prospectus dated Wed 25 Feb 2026

Bid dates
Fri 20 Feb 2026 to Tue 24 Feb 2026
Listing date
Fri 27 Feb 2026
Issue price
₹79 per share

Listed on BSE and NSE on Fri 27 Feb 2026.

Listing price ₹83

Opening price on BSE on the listing day (BSE daily price file for Fri 27 Feb 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹79 per share
Prospectus dated Wed 25 Feb 2026, page 3
Lot size
Not stated in the prospectus
Prospectus dated Wed 25 Feb 2026
Lot amount at the upper band
Not stated in the prospectus
Prospectus dated Wed 25 Feb 2026
Issue size at the upper band
₹165.00 crore
Fresh issue
₹90.00 crore
Prospectus dated Wed 25 Feb 2026, page 77
Offer for sale
₹75.00 crore
Prospectus dated Wed 25 Feb 2026, page 77
Bid dates
Fri 20 Feb 2026 to Tue 24 Feb 2026
Prospectus dated Wed 25 Feb 2026, page 2
Listing date
Fri 27 Feb 2026
BSE daily price file for Fri 27 Feb 2026
Anchor lock-in ends
Not stated in the prospectus
Prospectus dated Wed 25 Feb 2026
Risk factors
65
Prospectus dated Wed 25 Feb 2026, page 76

Timeline (IST)

  1. OpensFri 20 Feb 2026, 10:00 am IST confirmedProspectus dated Wed 25 Feb 2026, page 2
  2. ClosesTue 24 Feb 2026 confirmedProspectus dated Wed 25 Feb 2026, page 2
  3. UPI mandate cut-offNot stated in the prospectus Prospectus dated Wed 25 Feb 2026
  4. AllotmentWed 25 Feb 2026 by T+3 schedule
  5. Refund and unblockThu 26 Feb 2026 by T+3 schedule
  6. Shares to dematThu 26 Feb 2026 by T+3 schedule
  7. ListingFri 27 Feb 2026 confirmedBSE daily price file for Fri 27 Feb 2026

Objects of the issue

ObjectAmount
Funding capital expenditure towards establishment of New IVF Centers of our Company₹50.00 crore
Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company₹20.00 crore
General Corporate Purposes₹12.28 crore
Total₹82.28 crore

The ₹75.00 crore offer for sale goes to the selling shareholders, not the company. Prospectus dated Wed 25 Feb 2026, page 104

Company and promoters

As described in the prospectus

Our company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years.

Prospectus dated Wed 25 Feb 2026, page 27

Promoters

  • 3 individual promoters

Prospectus dated Wed 25 Feb 2026, page 27

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group99.98%71.30%

Prospectus dated Wed 25 Feb 2026, page 97

Financials (restated)

ItemPeriod ended September 30, 2025Fiscal 2025Fiscal 2024Fiscal 2023
Revenue from operations₹49.50 crore₹70.72 crore₹47.89 crore₹44.24 crore
Profit after tax₹12.51 crore₹19.13 crore₹10.32 crore₹13.53 crore
Net worth₹58.85 crore₹46.30 crore₹26.99 crore₹22.73 crore
Total borrowingsNot stated in the prospectusNot stated in the prospectusNot stated in the prospectusNot stated in the prospectus

Prospectus dated Wed 25 Feb 2026, page 82

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Individual shareholderIndividual94,93,700Not stated in the prospectus
Total offer for sale₹75.00 crore

Prospectus dated Wed 25 Feb 2026, page 77

Peer comparison (as in the Prospectus)

CompaniesFace Value (₹)Total Revenue (₹in Lakh.)PAT (₹ in Lakhs)Basic EPS (₹)P/E RatioRoNW (%)Closing Price (₹)NAV (₹ per equity share)
Gaudium IVF and Women Health Limited57,095.841,912.743.12-41.71%-7.54
Progyny Inc.$0.00011,012,895.0646,524.2250.5241.5612.90%2,099.48394.20
Inspire IVF Public Company LimitedTHB 0.052,695.39551.070.1711.433.97%1.994.34

Reproduced from the Prospectus dated Wed 25 Feb 2026, page 127; InsightPier adds no figures

Risk factors

65 total
  1. Contingent liabilities not provided for are large relative to net worth (offer document page 37)
  2. Fertility care carries operational, reputational, medical and legal risks (offer document page 38)
  3. The business depends on attracting and keeping doctors, nurses and other professionals (offer document page 39)
  4. Related party transactions may involve conflicts of interest (offer document page 41)
  5. Future share issues or sales could lower the share price (offer document page 76)

All 65 risk factors, pages 36 to 76

Offer document

Allotment and bids

Registrar to the issue: Bigshare Services Private Limited.

Allotment status was expected on the registrar's site from Wed 25 Feb 2026 and is not yet confirmed. Pick "GAUDIUM IVF AND WOMEN HEALTH LIMITED" from the issue list there.

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts